{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:28:16Z","timestamp":1761805696847,"version":"build-2065373602"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The association between glomerular diseases and malignancies has been recognized since the 1920s. A diverse spectrum of glomerular lesions can occur in various neoplasms, including both hematologic malignancies and solid tumors. This study presents a case series of paraneoplastic nephrotic syndrome (PNS) associated with three solid tumors: ovarian cancer, pancreatic neuroendocrine tumor (NET), and bladder cancer. The occurrence of PNS is rarely reported in association with these malignancies. Notably, all patients achieved complete or partial remission without receiving corticosteroids or immunosuppressant therapy. These observations accentuate the critical role of malignancy in the pathogenesis of glomerulopathy and underscore the therapeutic primacy of oncological control in such patients.<\/jats:p>","DOI":"10.3389\/fmed.2025.1609192","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:23:18Z","timestamp":1761805398000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Glomerular disease associated with cancer: a case series of paraneoplastic nephrotic syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Mengsi","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"ref1","first-page":"1201","article-title":"Remarks ON HODGKIN'S DISEASE","volume-title":"Br Med J","author":"Galloway","year":"1922"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/ndt\/4.11.947","article-title":"Proteinuria and haematuria are frequently present in patients with lung cancer","volume":"4","author":"Puolijoki","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/bmj.296.6632.1295","article-title":"Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies","volume":"296","author":"Sawyer","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e20240131","DOI":"10.1590\/2175-8239-jbn-2024-0131en","article-title":"Potentially paraneoplastic glomerulopathies in a Brazilian cohort: a retrospective analysis","volume":"47","author":"Laferreira","year":"2025","journal-title":"J Bras Nefrol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrneph.2010.171","article-title":"Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis","volume":"7","author":"Lien","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","article-title":"Paraneoplastic glomerulopathies: new insights into an old entity","volume":"56","author":"Ronco","year":"1999","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","article-title":"Paraneoplastic glomerular diseases and malignancies","volume":"70","author":"Bacchetta","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40620-015-0234-9","article-title":"Glomerular diseases and cancer: evaluation of underlying malignancy","volume":"29","author":"Pani","year":"2016","journal-title":"J Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.kint.2020.07.039","article-title":"NELL1 is a target antigen in malignancy-associated membranous nephropathy","volume":"99","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/sj.ki.5001790","article-title":"Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association","volume":"70","author":"Lefaucheur","year":"2006","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2215\/CJN.03770412","article-title":"Onco-nephrology: glomerular diseases with cancer","volume":"7","author":"Cambier","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000546050","article-title":"Paraneoplastic Glomerulopathies: mechanistic and pathogenic insights","volume":"23","author":"Royal","year":"2025","journal-title":"Am J Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"sfaf101","DOI":"10.1093\/ckj\/sfaf101","article-title":"Malignancies and glomerulonephritis: when to suspect and when to screen?","volume":"18","author":"Murt","year":"2025","journal-title":"Clin Kidney J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.kint.2020.06.046","article-title":"KDIGO controversies conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer","volume":"98","author":"Porta","year":"2020","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40620-024-02084-6","article-title":"Minimal change glomerular disease associated with solid neoplasms: a systematic review","volume":"38","author":"Cozzo","year":"2024","journal-title":"J Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.semnephrol.2010.09.011","article-title":"Membranous nephropathy and malignancy","volume":"30","author":"Beck","year":"2010","journal-title":"Semin Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/0003-4819-64-1-41","article-title":"The association of cancer and the nephrotic syndrome","volume":"64","author":"Lee","year":"1966","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4103\/1319-2442.113883","article-title":"Profound nephrotic syndrome in a patient with ovarian teratoma","volume":"24","author":"Jeroudi","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref20","first-page":"513","article-title":"Ovarian cancer associated with the nephrotic syndrome","volume":"70","author":"Hoyt","year":"1987","journal-title":"Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/BF00441515","article-title":"Membranous nephropathy associated with ovarian tumour in a young girl: recovery after removal","volume":"148","author":"Beauvais","year":"1989","journal-title":"Eur J Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/pgmj.70.825.505","article-title":"Systemic amyloidosis and ovarian carcinoma","volume":"70","author":"Fernandez-Miranda","year":"1994","journal-title":"Postgrad Med J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000046219","article-title":"Membranoproliferative glomerulonephritis associated with a mixed-cell germinal ovary tumor","volume":"21","author":"Salazar-Exaire","year":"2001","journal-title":"Am J Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/gyno.2000.6029","article-title":"Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration","volume":"80","author":"Forgy","year":"2001","journal-title":"Gynecol Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3349\/ymj.2003.44.3.539","article-title":"A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma","volume":"44","author":"Kim","year":"2003","journal-title":"Yonsei Med J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ygyno.2004.02.022","article-title":"Minimal change disease in a patient with ovarian papillary serous carcinoma","volume":"93","author":"Ryu","year":"2004","journal-title":"Gynecol Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.12659\/AJCR.883583","article-title":"Nephrotic syndrome associated with gemcitabine use in a patient with ovarian cancer","volume":"13","author":"Ata","year":"2012","journal-title":"Am J Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3109\/0886022X.2013.780614","article-title":"Unspecific increase of tumor markers in a girl with nephrotic syndrome and ovarian teratoma","volume":"35","author":"Kilis-Pstrusinska","year":"2013","journal-title":"Ren Fail"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/ndtplus\/sfr106","article-title":"Minimal-change disease as a paraneoplastic syndrome in a patient with ovarian carcinoma","volume":"4","author":"Gonz\u00e1lez-Fontal","year":"2011","journal-title":"NDT Plus"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00467-011-1994-7","article-title":"An unusual case of membranous nephropathy associated with an ovarian tumor","volume":"26","author":"Chen","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.11604\/pamj.2019.34.75.6008","article-title":"Ovarian tumor and glomerulopathies: case report and review of the literature","volume":"34","author":"Benabdellah","year":"2019","journal-title":"Pan Afr Med J"},{"key":"ref32","first-page":"108","article-title":"Membranous nephropathy as a paraneoplastic syndrome in a patient with ovarian serous Cystadenofibroma - case report","volume":"17","author":"Ana Stojanoska","year":"2019","journal-title":"Bantao Journal"},{"key":"ref33","first-page":"555","article-title":"Cical aspects of the nephrotic syndrome in systemic diseases","volume-title":"Nephrotic syndrome","author":"Torres","year":"1988"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e48787","DOI":"10.7759\/cureus.48787","article-title":"Bevacizumab-induced nephropathy presenting as crescentic Glomerulopathy","volume":"15","author":"Onteddu","year":"2023","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12882-025-04385-9","article-title":"Bevacizumab-associated glomerular microangiopathy: a case report and literature review","volume":"26","author":"Jiang","year":"2025","journal-title":"BMC Nephrol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.21037\/tcr-24-1276","article-title":"A new risk algorithm combining D-dimer and HE4 differentiates borderline tumor from patients with ovarian tumor","volume":"14","author":"Zhang","year":"2025","journal-title":"Transl Cancer Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/labmed\/lmx036","article-title":"Human epididymis protein 4 as a potential biomarker of chronic kidney disease in female patients with Normal ovarian function","volume":"48","author":"Yuan","year":"2017","journal-title":"Lab Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/cncr.28721","article-title":"Gastroenteropancreatic high-grade neuroendocrine carcinoma","volume":"120","author":"Sorbye","year":"2014","journal-title":"Cancer"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.cgh.2011.08.018","article-title":"A pancreatic mass and bilateral pitting pedal edema: nothing is ever what it seems","volume":"10","author":"Gleeson","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5414\/CNP75042","article-title":"Remission of membranous glomerulonephritis after pancreatectomy for pancreatic neuroendocrine neoplasm - a rare coincidence","volume":"75","author":"Forslund","year":"2011","journal-title":"Clin Nephrol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e56660","DOI":"10.7759\/cureus.56660","article-title":"A case of acute kidney injury, proteinuria, and thrombotic Microangiopathy associated with Sunitinib therapy in metastatic pancreatic neuroendocrine tumor","volume":"16","author":"Singh","year":"2024","journal-title":"Cureus"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/jcp-2024-209851","article-title":"Sunitinib induced glomerular thrombotic microangiopathy in a patient with refractory pancreatic neuroendocrine tumour","volume":"78","author":"Khan","year":"2024","journal-title":"J Clin Pathol"},{"key":"ref47","first-page":"89","volume-title":"A case of bladder tumor associated with nephrotic syndrome","author":"Fukushi","year":"1978"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/00365599709070351","article-title":"Nephrotic syndrome associated with transitional cell carcinoma of urinary bladder","volume":"31","author":"Reshi","year":"1997","journal-title":"Scand J Urol Nephrol"},{"key":"ref49","first-page":"65","article-title":"Membranous glomerulonephritis and transitional cell carcinoma, improved proteinuria after each tumor resection","volume":"20","author":"Fabbian","year":"2003","journal-title":"G Ital Nefrol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12882-021-02457-0","article-title":"Recurrent membranous nephropathy with a possible alteration in the etiology: a case report","volume":"22","author":"Matsumoto","year":"2021","journal-title":"BMC Nephrol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2453-a","DOI":"10.1093\/ndt\/gfg391","article-title":"Systemic AA amyloidosis and nephrotic syndrome associated with small cell carcinoma of the bladder","volume":"18","author":"Kanat","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/iju5.12335","article-title":"Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms","volume":"4","author":"Mizusawa","year":"2021","journal-title":"IJU Case Rep"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000185579","article-title":"Nephrotic syndrome associated with transitional cell carcinoma of the bladder","volume":"52","author":"Rapoport","year":"1989","journal-title":"Nephron"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/08860220601098961","article-title":"Nephrotic syndrome as a complication of intravesical BCG treatment of transitional cell carcinoma of urinary bladder","volume":"29","author":"Singh","year":"2007","journal-title":"Ren Fail"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s11864-024-01270-9","article-title":"Targeting the renin-angiotensin-aldosterone system (RAAS) for cardiovascular protection and enhanced oncological outcomes: review","volume":"25","author":"Pawlonka","year":"2024","journal-title":"Curr Treat Options in Oncol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/life10110268","article-title":"Cancer stem cells in head and neck metastatic malignant melanoma express components of the renin-angiotensin system","volume":"10","author":"Siljee","year":"2020","journal-title":"Life (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/ijms26031389","article-title":"Cancer stem cells and the renin-angiotensin system in the tumor microenvironment of melanoma: implications on current therapies","volume":"26","author":"Kilmister","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12964-020-0531-3","article-title":"The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun Signal"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5144\/0256-4947.2025.18","article-title":"Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer","volume":"45","author":"Sever","year":"2025","journal-title":"Ann Saudi Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fmed.2018.00170","article-title":"Molecular and cellular mechanisms for proteinuria in minimal change disease","volume":"5","author":"Bertelli","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00018-012-1082-6","article-title":"Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma","volume":"70","author":"Stuchlova Horynova","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1055\/s-0038-1669413","article-title":"Antiglomerular Basement Membrane Disease","volume":"39","author":"McAdoo","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2215\/CJN.05270515","article-title":"Autoantibodies against linear epitopes of myeloperoxidase in anti-glomerular basement membrane disease","volume":"11","author":"Li","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/gyno.2001.6575","article-title":"Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study","volume":"85","author":"Topalak","year":"2002","journal-title":"Gynecol Oncol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/antib9020018","article-title":"Glomerular diseases associated with malignancies: histopathological pattern and association with circulating autoantibodies","volume":"9","author":"Lionaki","year":"2020","journal-title":"Antibodies"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1609192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:23:20Z","timestamp":1761805400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1609192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":68,"alternative-id":["10.3389\/fmed.2025.1609192"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1609192","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"article-number":"1609192"}}